Transcript: Which HIV Meds Cause Lipoatrophy?

Transcript: Beyond Condoms: Medical Approaches For Prevention

Transcript: Simple Test Eliminates Abacavir Risk

Transcript: Are We Starting Treatment Early Enough?

Transcript: The Latest on Lipo: Advances & Setbacks

Prezista Superior to Kaletra for Treatment-Experienced Patients
Preliminary results from a major clinical trial have demonstrated that Prezista plus Norvir is more effective than Kaletra in treatment-experienced HIV-positive patients.

NNRTI Etravirine Effective for Treatment-Experienced Patients
Studies reviewed at the fourth IAS Conference in Sydney indicate that Tibotec's NNRTI etravirine, combined with the company's PI Prezista, is safe and effective for treatment-experienced HIV-positive patients.

PRO 140 Shows Promise in Single-Dose Study
Researchers have reported encouraging results from an early study of PRO 140, an experimental HIV entry inhibitor.

Hershey School Asks Court If It Violated HIV Discrimination Law

Controversy on Publication of AIDS Denialism Paper Continues

Pet Owner Among Social Roles Helpful for Women With HIV

Antibiotics Losing Battle Against Gonorrhea
The last line of defense against gonorrhea is losing its effectiveness against the gonorrhea, according to a new article published February 9 in the The New England Journal of Medicine. With no new antibiotics effective against the sexually transmitted infection (STI) on the horizon, Gail Bolan, MD, of the U.S. Centers for Disease Control and her fellow authors, are worried about an upswing in gonorrhea samples showing to be less susceptible to cephalosporins—the only class of drugs active against the bacteria resistant to other standard treatments.

Merck Warns of Victrelis and HIV Protease Inhibitor Interactions
The hepatitis C protease inhibitor Victrelis (boceprevir) has some significant drug-drug interactions with common Norvir (ritonavir)?boosted protease inhibitor (PI) combinations, according to preliminary data from a clinical trial and a warning issued to health care providers by Merck on February 6. 

Spinal Cord Stimulation Shows Potential for Peripheral Neuropathy
Electrical stimulation of the spinal cord markedly reduced peripheral neuropathy (PN)–associated pain in a man living with HIV who didn’t respond to more conventional PN therapies, according to a February 5 presentation at the 6th World Congress of the World Institute of Pain in Miami and reported by Medscape. 

CDC Recommends HPV Vaccine for Boys and Young Men, Hep B Vaccine for Diabetics
It’s official: All males between 11 and 21 years of age should be vaccinated against human papillomavirus (HPV), a leading cause of oral, genital and anal cancers, according to new U.S. Centers for Disease Control and Prevention guidelines published February 3 in the health agency’s Morbidity and Mortality Weekly Report. HPV vaccination is also recommended for previously unvaccinated men between 22 and 26 years of age who have compromised immune systems, are HIV positive or have sex with other men. 

Isentress, Intelence, Prezista Regimen Goes the Distance for HIV Treatment Veterans
A drug regimen containing Isentress (raltegravir), Intelence (etravirine) and Norvir (ritonavir)–boosted Prezista (darunavir) has been shown to be “highly potent and durable in terms of efficacy and safety” in a French clinical trial involving heavily treatment-experienced people living with HIV. According to the research paper published ahead of print by the Journal of Acquired Immune Deficiency Syndromes (JAIDS), 88 percent of those using this regimen had undetectable viral loads after nearly two years of treatment.

Awareness, Testing Needed to Curb Hep C Infections Among HIV-Positive Gay Men
A new report by the National AIDS Trust (NAT), a leading HIV organization in the United Kingdom, concludes that much more needs to be done to address the burgeoning epidemic of hepatitis C virus (HCV) infection among gay men living with HIV.

Back in the Driver’s Seat
For Wayne Starks, 51, a former New York City bus driver and the father of two, finding the strength to stay sober has been central to his fight to stay healthy while living with both HIV and hepatitis C virus (HCV). His life has taken some unexpected turns along the way, but as he explains here, Starks has managed to steer himself on the road to wellness.